- Did you use an Abbott Freestyle Libre 3 sensor continuous glucose monitoring device?
- Did inaccurate blood sugar readings lead to hospitalization?
- Did you suffer a seizure, coma, or other life-threatening complications as a result of inaccurate blood glucose reading?
Abbott Recall and FDA Early Alert
Acknowledging that its FreeStyle Libre 3 Sensor and Sensor Plus blood glucose monitors may give inaccurate results of either low or high blood glucose levels, Abbott recalled the devices: https://abbott.mediaroom.com/press-releases?item=124718
The inaccurate readings can lead patients to either use too much or not enough insulin. Seven deaths and 860 serious adverse events have been reported.
As a result, the U.S. Food and Drug Administration issued an Early Alert advising patients and physicians to stop using affected lots. The FDA Early Alert with a listing of the affected lots can be found here: https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/glucose-monitor-sensor-recall-abbott-diabetes-care-removes-certain-freestyle-libre-3-and-freestyle
Who May Be Entitled to Compensation
You may be entitled to compensation if you or a loved one experienced any of the following from inaccurate blood glucose monitoring from the Freestyle Libre:
- Hospitalization of ER Visit
- Serious Medical Complications, Such as Seizures or a Diabetic Coma
- Death
- Insulin Overdose or Underdose
- Ongoing Medical Care or Monitoring
